Print Page | Contact Us | Sign In | Join
Industry News: News

Surgery in a Syringe: A Minimally Invasive Alternative to Surgical Liposuction

Tuesday, July 23, 2019   (1 Comments)
Share |

Among the available nonsurgical cosmetic procedures, body contouring treatments, and the use of injectables for aesthetic improvement, continue to gain popularity. As a modality for reducing unwanted adipose tissue, injection adipocytolysis, is an approach to body contouring that accommodates the growing patient inclination toward minimally invasive treatments.

ATX-101 injection (deoxycholic acid injection 10 mg/mL), from Allergan, Inc., known as Kybella in the U.S, and Belkyra in Canada, is the first FDA-approved pharmaceutical therapy for injection adipocytolysis.


anil rajani says...
Posted Saturday, July 27, 2019
Good info. many of us used this in 2003-2009 on a regular basis in the volumes you mention. It is interesting reading however what would you advise for those at this point in time. You refer to it as atx-101, now I presume owned by Allergan thus you mean Kybella. 90 cc would cost a patient about 22k if my quick math is correct? I'm assuming you are directing our thoughts to using generic versions for this application? Thank s for writing the article and direction to the purpose of it. There are many papers on PC-DC combinations and outcomes/ side effects.

Contact Us

224 N Desplaines, Ste. 600S
 Chicago, IL 60661

Phone: 312-981-0993

Fax: 888-827-8860


AmSpa provides legal, compliance, and business resources for medical spas and medical aesthetic practices.

Follow Us: